News

Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today…
Read More...

AMRI announced that it has entered into an agreement with the pharmaceutical group Ferrer  and Accord Healthcare, Inc. ("Accord Healthcare") to jointly develop and manufacture an…
Read More...

Amphastar Pharmaceuticals Inc said on Tuesday that the U.S. Food and Drug Administration had rejected its application to market an intranasal version of the emergency opioid-overdose…
Read More...

Valeant Pharmaceuticals International, Inc. and EyeGate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing products for treating…
Read More...

Abzena has entered into a manufacturing agreement with University College London (UCL). Under the agreement, Abzena will manufacture Magacizumab, an antibody created using the…
Read More...

Xbrane Biopharma has been granted GMP (Good Manufacturing Practice) certification for its Spherotide production facility by AIFA, the Italian Medicines Agency. The GMP certification…
Read More...

ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been awarded a…
Read More...

CanniMed Therapeutics Inc. and CTT Pharmaceutical Holdings Inc.have entered into a definitive contractual relationship for the licensing of CTT’s Orally Dissolvable Thin Film (ODF)…
Read More...

Immune Pharmaceuticals Inc., will announce on Monday, February 20th, 2017 at the Acute Leukemia XVI symposium in Munich, Germany that it will be launching REMAIN™, an international…
Read More...

The US Food and Drug Administration has accepted for filing of Intellipharmaceutics International’s New Drug Application ("NDA") seeking authorization to market its Rexista…
Read More...

Momenta Pharmaceuticals has announced that Pfizer, Sandoz’s contracted Glatopa (glatiramer acetate injection) fill/finish manufacturing partner has received a warning letter from the…
Read More...

Global healthcare and life science company Arix Bioscience has raised £100m in its Initial Public Offering (IPO) on the main market of the London Stock Exchange. The Offer was…
Read More...

Otsuka Pharmaceutical Co., Ltd. and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI (brexpiprazole) for the treatment of schizophrenia in adults.…
Read More...

Dauntless Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the development of specialty therapeutics announced the initiation of a Phase 1 clinical study to…
Read More...

Imprimis Pharmaceuticals, Inc.an ophthalmology-focused pharmaceutical company announced that it has begun shipping its core sterile ophthalmic medications to select customers from its…
Read More...

Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash. Takeda president and CEO Christophe Weber said: “We are very pleased to…
Read More...

Solasia Pharma K.K. and Lee’s Pharmaceutical Holdings Limited jointly announced that Solasia and Lee’s Pharma have entered into an exclusive agreement for the commercialization and…
Read More...

Mayne Pharma Group Limited announced the launch of butalbital acetaminophen (APAP) tablets 50 mg/300 mg in the United States. Butalbital / APAP is indicated for the treatment of tension…
Read More...

X-Chem, Inc. announced that it has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new drug…
Read More...

Catalent  announced that it has completed the acquisition of Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency…
Read More...